FdaApplication
NDA 206334
Identifiers
- fda_app_no: NDA206334
Properties
| Property | Value |
|---|---|
| applicant_name | MELINTA THERAPEUTICS LLC |
| application_type | NDA |
| approval_date | 2014-08-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ORBACTIV | ORITAVANCIN DIPHOSPHATE | EQ 400MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product